JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
Innoviz Technologies
INVZ
$108M
| $3M | ﹤0.01% |
766,026
+362,143
| +90% | +$1.41M |
2021 Q4
2 quarters
|
|
3077
Mesa Laboratories
MLAB
$742M
| $2.99M | ﹤0.01% |
14,662
-376
| -3% | -$82.3K |
2017 Q4
18 quarters
|
|
3078
Champion Homes
SKY
$4.78B
| $2.99M | ﹤0.01% |
63,022
+2,720
| +5% | +$140K |
2016 Q4
22 quarters
|
|
3079
BOK Financial
BOKF
$7.8B
| $2.98M | ﹤0.01% |
39,479
+16,600
| +73% | +$1.4M |
2019 Q2
12 quarters
|
|
|
FFWM
3080
DELISTED
First Foundation Inc
FFWM
| $2.98M | ﹤0.01% |
145,720
+7,166
| +5% | +$159K |
2016 Q4
22 quarters
|
|
3081
CALL
Agilent Technologies
A
$47.3B
| $2.98M | ﹤0.01% |
+25,100
| New | +$3.09M |
2022 Q2
0 quarters
|
|
3082
Equinor
EQNR
$101B
| $2.98M | ﹤0.01% |
85,672
-54,021
| -39% | -$1.93M |
2013 Q2
36 quarters
|
|
3083
WIX.com
WIX
$3.04B
| $2.98M | ﹤0.01% |
45,419
+1,049
| +2% | +$76.8K |
2015 Q1
29 quarters
|
|
3084
Dorchester Minerals
DMLP
$1.41B
| $2.98M | ﹤0.01% |
124,769
-67
| -0.1% | -$1.84K |
2013 Q2
36 quarters
|
|
|
SMC
3085
Summit Midstream
SMC
$425M
| $2.97M | ﹤0.01% |
233,022
+221
| +0.1% | +$3.85K |
2021 Q1
5 quarters
|
|
3086
ChargePoint
CHPT
$249M
| $2.96M | ﹤0.01% |
10,795
+1,948
| +22% | +$540K |
2020 Q1
9 quarters
|
|
3087
CALL
Diamondback Energy
FANG
$51.7B
| $2.96M | ﹤0.01% |
24,400
-17,100
| -41% | -$2.34M |
2022 Q1
1 quarter
|
|
3088
Under Armour Class C
UA
$1.97B
| $2.95M | ﹤0.01% |
389,424
+200,452
| +106% | +$2.25M |
2016 Q2
24 quarters
|
|
3089
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.07B
| $2.95M | ﹤0.01% |
48,130
-70,826
| -60% | -$4.59M |
2015 Q4
26 quarters
|
|
3090
Adtran
ADTN
$574M
| $2.94M | ﹤0.01% |
168,019
-109,061
| -39% | -$1.97M |
2015 Q3
27 quarters
|
|
3091
Denali Therapeutics
DNLI
$3.2B
| $2.94M | ﹤0.01% |
100,025
+2,653
| +3% | +$69.5K |
2018 Q1
17 quarters
|
|
3092
Sibanye-Stillwater
SBSW
$7.05B
| $2.94M | ﹤0.01% |
294,594
-60,548
| -17% | -$791K |
2013 Q2
36 quarters
|
|
3093
Stock Yards Bancorp
SYBT
$2.44B
| $2.93M | ﹤0.01% |
48,995
+25,762
| +111% | +$1.44M |
2013 Q2
36 quarters
|
|
|
ACAH
3094
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
| $2.93M | ﹤0.01% |
299,661
-220,854
| -42% | -$2.16M |
2021 Q2
4 quarters
|
|
3095
Novavax
NVAX
$1.73B
| $2.93M | ﹤0.01% |
56,991
-13,345
| -19% | -$691K |
2014 Q3
31 quarters
|
|
3096
ESAB
ESAB
$4.35B
| $2.92M | ﹤0.01% |
+66,701
| New | +$3.22M |
2022 Q2
0 quarters
|
|
3097
CALL
Western Digital
WDC
$150B
| $2.91M | ﹤0.01% |
85,995
+20,771
| +32% | +$834K |
2020 Q3
7 quarters
|
|
|
MYOV
3098
DELISTED
Myovant Sciences Ltd.
MYOV
| $2.91M | ﹤0.01% |
234,391
+218,733
| +1,397% | +$2.41M |
2016 Q4
22 quarters
|
|
3099
iShares US Healthcare ETF
IYH
$3.83B
| $2.91M | ﹤0.01% |
54,050
-835
| -2% | -$45.8K |
2013 Q2
36 quarters
|
|
|
RMGC
3100
DELISTED
RMG Acquisition Corp. III Class A Ordinary Shares
RMGC
| $2.9M | ﹤0.01% |
+295,000
| New | +$2.9M |
2022 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.